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ABSTRACT
Aims In pregnant smoking cessation trial participants, to estimate (1) amongwomen abstinent at the end of pregnancy,
the proportion who re-start smoking at time-points afterwards (primary analysis) and (2) among all trial participants, the
proportion smoking at the end of pregnancy and at selected time-points during the postpartum period (secondary analy-
sis).Methods Trials identiﬁed from two Cochrane reviews plus searches of Medline and EMBASE. Twenty-seven
trials were included. The included trials were randomized or quasi-randomized trials of within-pregnancy cessa-
tion interventions given to smokers who reported abstinence both at end of pregnancy and at one or more de-
ﬁned time-points after birth. Outcomes were validated biochemically and self-reported continuous abstinence
from smoking and 7-day point prevalence abstinence. The primary random-effects meta-analysis used longitudi-
nal data to estimate mean pooled proportions of re-starting smoking; a secondary analysis used cross-sectional
data to estimate the mean proportions smoking at different postpartum time-points. Subgroup analyses were per-
formed on biochemically validated abstinence. Results The pooled mean proportion re-starting at 6 months
postpartum was 43% [95% conﬁdence interval (CI) = 16–72%, I2 = 96.7%] (11 trials, 571 abstinent women).
The pooled mean proportion smoking at the end of pregnancy was 87% (95% CI = 84–90%, I2 = 93.2%) and
94% (95% CI = 92–96%, I2 = 88%) at 6 months postpartum (23 trials, 9262 trial participants). Findings were
similar when using biochemically validated abstinence. Conclusions In clinical trials of smoking cessation in-
terventions during pregnancy only 13% are abstinent at term. Of these, 43% re-start by 6 months postpartum.
Keywords Meta-analysis, postpartum period, pregnancy, randomized controlled trial, re-starting smoking, smoking,
smoking cessation, smoking cessation interventions, systematic review, tobacco.
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INTRODUCTION
Tobacco smoking during pregnancy remains a major
global public health issue [1]; a conservative estimate
for the annual economic burden in the United Kingdom
is £23.5 million [2] and in the United States $110 mil-
lion [3]. Although in developed countries the prevalence
of smoking is declining and is currently approximately
10–27% [4–8], rates are higher and rising in developing
countries [9,10] Most women quit spontaneously upon
ﬁnding out that they are pregnant, with approximately
38–62% achieving abstinence [5,6,11–13]. Unfortu-
nately, many re-start smoking after childbirth and in so
doing increase their risks of smoking-related morbidities,
as well as their offspring’s risks of passive smoking-
associated morbidities [14–16] and becoming smokers
themselves. [17].
Cessation interventions can be both effective and
cost-effective at supporting pregnant smokers’ quit
attempts [18–21], and signiﬁcant money and effort is
spent on helping pregnant women to stop, with both
developing and developed countries investing in cessa-
tion support [22–24]. For example, approximately
21 780 pregnant smokers in the United Kingdom
(15% of pregnant smokers and 3% of all maternities)
accessed National Health Service (NHS) Stop Smoking
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Services in the ﬁnancial year 2012–13, 47% of whom
achieved cessation by 4 weeks after a quit date, at a cost
of £235 per quitter and total costs of £5 118 300
[25,26]. Unfortunately, high rates of re-starting smoking
after childbirth may mean that this expenditure has fewer
beneﬁcial health effects than it could; knowing how many
pregnant smokers who, in supported quit attempts, stop
smoking during pregnancy but then re-start smoking af-
terwards would help to quantify this. Data from cohort
studies of pregnant smokers who are spontaneous quitters
and not documented as having received cessation support
show that 46–76% of women who stop smoking in preg-
nancy re-start smoking during the months after birth
[12,27–30]. However, women who receive smoking ces-
sation support in pregnancy, such as those who use UK
NHS Stop Smoking Services, may be different from spon-
taneous quitters; for example, they may be more
nicotine-dependent and hence ﬁnd it harder to quit
[12,31] Therefore, we cannot assume that rates of
re-starting smoking after childbirth among pregnant
smokers who seek and obtain support will be the same
as those among unsupported, ‘spontaneous’ quitters.
Hence, in this paper, we use longitudinal, prolonged absti-
nence data from smoking cessation trials which enrolled
pregnant smokers to describe the rates and timing of
pregnant smokers’ return to smoking after childbirth.
We contextualize rates of return to smoking by synthesiz-
ing, in analyses, point prevalence smoking status data
collected across studies at different postpartum time-
points and summarizing the proportions of women
smoking at each.
METHODS
Rationale for inclusion of studies
It was anticipated that robust data on smoking behav-
iour during and after pregnancy would be reported by
trials identiﬁed for inclusion from two recent
Cochrane systematic reviews which investigated
behavioural [18] and pharmacological smoking cessa-
tion interventions used during pregnancy [19].
Searches were updated, being run until 4 March
2015; search strategy details can be found in
Supporting information, ﬁle 1. For ongoing trials, at-
tempts were made to contact the principal investiga-
tors to obtain available results.
Participants
Pregnant smokers in any care setting who could be
considered to have motivation to stop smoking were
included. Women who consented to join smoking
cessation trials were assumed to be motivated to quit
(see ‘Study design’).
Interventions
Any intervention(s) aimed to encourage smoking cessation
during pregnancy. Control group participants could receive
placebo, another cessation intervention or no intervention.
Outcomes
Biochemically validated continuous abstinence from end of
pregnancy to at least one postpartum follow-up point or
biochemically validated 7-day point prevalence abstinence
reported at both the end of pregnancy and at least one
postpartum follow-up point. For all outcomes, self-reported
data were accepted if validation was not conducted.
Study design
We aimed to include trials which enrolled participants who,
similar to pregnant smokers who seek out and receive
smoking cessation support, could be considered motivated
to try to stop smoking. Hence, we included trials with
individual-level randomization or quasi-randomization (e.g.
by days of the week or on alternate days), because partici-
pants who consented to join a cessation-orientated study
could be considered to have some motivation to quit.
Cluster trials were included only if participants, despite be-
ing randomized within clusters, also consented individually
to join the study and hence could be considered to have mo-
tivation for cessation.
Exclusion criteria
Studies were excluded if: (1) intervention(s) were delivered
to women who were not smoking; (2) data were presented
in a format that could not be analysed and further informa-
tion was not forthcoming from authors; (3) they enrolled
smokers and ‘recent quitters’ but did not report outcomes
separately; and (4) they did not have ﬁxed postpartum
follow-up time-points.
Data extraction
Abstracts for identiﬁed articles were screened by two re-
viewers and those deemed relevant were retrieved in full;
two reviewers extracted data and performed quality assess-
ments independently, discussing any discrepancies until
agreement was secured. A summary of the data extracted
is shown in Table 1.
Quality assessment
Quality assessment was conducted by two reviewers using
the Cochrane ‘Risk of bias’ tool developed by Higgins et al.
[32], with two modiﬁcations. Under the heading ‘Attrition
bias’, we noted whether the statistical analysis had been
conducted on an intention-to-treat basis such that
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participants lost to follow-up were considered to be
smoking [33]. Under ‘Other bias’, it was recorded whether
biochemical validation of abstinence had been undertaken,
the method used and upon which participants this was
conducted.
Data synthesis
To minimize potential heterogeneity, as far as possible
only data collected at similar time-points were synthe-
sized. To achieve this, we tabulated follow-up time-points
reported across all trials and identiﬁed those used by the
greatest number of studies as time-points for data
pooling. Study data were allocated to review time-points
which were closest to the time that study data collection
had actually occurred. Where abstinence was reported
as occurring within a period, the soonest time after
childbirth was used to represent the time that cessation
occurred in analyses (e.g. a 6-month time-point was
used for cessation reported as occurring between 6 and
12 months after childbirth).
For our primary analysis we used individual women’s
longitudinally collected ‘continuous abstinence’ data to in-
vestigate the rates of re-starting smoking in those women
who reported abstinence at the end of pregnancy. Speciﬁ-
cally, we pooled the proportions of women who re-started
smoking at different postpartum follow-up points. The pro-
portion who re-started smoking was deﬁned as:
Proportion re-start smoking¼
Number re-started smoking at postpartum follow up
Number abstinent at the end of pregnancy
Studies which reported only point prevalence cessation
data were not used in this primary analysis, because point
prevalence data reﬂect a short period of abstinence. Using
this outcome, individuals can oscillate repeatedly between
abstinence to smoking, hence one cannot guarantee that
women reporting abstinence at postpartum follow-up
would be the same women as those reporting abstinence
at the end of pregnancy.
To contextualize the rates of re-starting smoking cal-
culated using longitudinal data we summarize, in a sec-
ondary, cross-sectional analysis, participants’ smoking
rates after childbirth by pooling the proportions of
women smoking in individual trials, with proportions de-
ﬁned as:
Proportion smoking¼
Number smoking at follow up
Total number of trial participants
For both primary and secondary analyses, we under-
took subgroup analyses restricted to those studies for
which biochemically validated abstinence were available.
As heterogeneity was anticipated, pooled mean propor-
tions and 95% conﬁdence intervals (CIs) were generated
Table 1 Summary of data extraction from included studies.
Category Data extracted
Background characteristics of trial Author(s)
Year published
Year(s) of conducting trial
Setting, including geographical location
Trial design
Description of subjects, including were women expecting to quit if reported
Unit of randomization
Details of control and experimental
interventions
Who is receiving the intervention?
What/who is involved in delivering the intervention?
What is the intensity of the intervention?
Statistical analysis All randomized participants included in ﬁnal analysis?
Which randomized participants were excluded from the analysis?
How were patients lost to follow-up treated (e.g. were they assumed to be smoking)?
Biochemical validation Was biochemical validation conducted during pregnancy, stating time-points?
Was biochemical validation conducted after pregnancy, stating time-points?
Biochemical validation cut-off point?
Was biochemical validation conducted on all abstinent smokers or on a sample?
General trial results Number of women eligible to recruit
Number recruited/randomized
Number lost to follow-up
Smoking behaviour Self-reported point prevalence/prolonged abstinence at reported time-points
(both within and after pregnancy)
Biochemically validated point prevalence/prolonged abstinence at reported
time-points (both within and after pregnancy)
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using a random-effects (DerSimonian & Laird) meta-
analysis, with statistical heterogeneity between trials
quantiﬁed using the I2 statistic. All analyses were con-
ducted using Stata version 14. [34]
RESULTS
Searches identiﬁed 913 possible studies, and 65 studies
were assessed by reading full texts with 27 being included
in the review (see Fig. 1). We contacted ongoing trials in-
vestigators in August 2014 and March 2015, but no
new studies were identiﬁed; we were unable to make con-
tact for two trials [35,36], and no results were available
for another [37]. Four studies reported continuous absti-
nence only [38–41], seven reported both continuous and
point-prevalence abstinence [42–48] and 16 reported
point-prevalence abstinence only [49–64] The primary
meta-analysis contained 571 women from 11 studies
[38–48], while the secondary meta-analysis included
9262 women from 23 studies [42–64] A summary of the
characteristics of included studies can be found in
Supporting information, ﬁle 2.
Twenty studies were randomized controlled trials (RCTs)
with individual randomization [38,40–43,46–54,59–64],
ﬁve were cluster-randomized [39,45,55–57] and two were
quasi-randomized [44,58] Of the cluster-randomized stud-
ies, all required participants to give consent to join the
study, therefore no cluster RCTs were excluded from the
review on the basis of not consenting women to join.
Control groups received information booklets in 15 stud-
ies [39,44–53,55,61,64]; counselling (eight studies)
[41,42,46,47,54,57,59,64]; placebo patches (three stud-
ies) [42,59,64]; one used non-contingent vouchers (re-
wards given to participants for attending the clinic) [53];
and one did not report what the control intervention was
[62] Three studies used ‘usual care’ as a control, but did
not deﬁne this [56,60,63], while one study reported using
‘usual care’ as provided by the UK NHS [40] The control
group received no intervention in one study [38]. Fourteen
studies reported using a single technique for the control in-
tervention [43–46,48–50,52,54,56–58,60,63].
For the intervention groups, 17 studies reported using in-
formation booklets [39,43–45,47–53,55,57,58,60,63,64],
20 reported using counselling [38,39,41–43,46–
49,51,52,54,55,57–61,63,64], four used nicotine
replacement therapy (NRT) [42,46,59,64], three used
social support interventions [39,49,54], two used moti-
vational interviewing (MVI) techniques [56,62] and two
used ﬁnancial incentives [40,50] The following
interventional approaches were employed in one study
each: ‘stages of change’ [45], contingent vouchers
(smoker rewarded for meeting certain criteria) [53], let-
ters of support [62] and physical activity [41]. Only four
studies used a single technique [38,44,56,61], with
most trials utilizing combinations of intervention strate-
gies. Nine studies reported the continuation of the cessa-
tion intervention into the postpartum period
[41,43,47,50,51,53,59,60,62].
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram
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Risk of bias assessment
The quality of included studies was generally judged to be
poor, and quality assessments of these can be found in
Supporting information, ﬁle 3. An intention-to-treat analy-
sis was not conducted in 19 studies [38,39,43,44,47–
53,55–58,60–63]; in others, participants were not in-
cluded in analyses for reasons such as miscarriage, prema-
ture birth, loss to follow-up, lost samples, moved
hospitals/areas, withdrawal of participation or being deliv-
ered interventions towhich they had not been randomized.
Eighteen studies used biochemical validation, with salivary
cotinine (ﬁve studies) [41,43,47,49,55], urinary cotinine
(six studies) [40,48,53,54,58,61], carbon monoxide
(seven studies) [39–42,51,59,61], salivary thiocynate
(one study) [50] or blood thiocynate (one study) [44].
Publication bias
Where possible, for all time-points at which data were
pooled, funnel plots were examined for evidence of bias;
however, only the end of pregnancy included all studies
and thus seemed the most pertinent. This plot suggested
that small studies with negative effect sizes were less likely
to be included in the review (see Supporting information,
ﬁle 4), so there is potential publication bias.
Selection of time-points
Included studies reported abstinence at 4–8 weeks post-
randomization (i.e. during pregnancy), at the end of preg-
nancyandat the following time-points postpartum: 10days
[45], 4 weeks [38], 6 weeks [48,49,52,55–58,62], 8 weeks
[44,50], 3months [46,47,53,54,62–64], 4months [56], 6
months [39–43,51–53,59,62], 8 months [60], 12 months
[42,64,65], 18 months [45] and 24 months [42]. Follow-
up data from studies were aggregated as follows: 4–8weeks
post-randomization; end of pregnancy (as deﬁned in
individual studies) and for postnatal time-points: 6 weeks
(data from 10 days and 4, 6 and 8 weeks after childbirth),
3 months (data from 3 and 4 months), 6 months (6 and 8
months), 12 months, 18 months and 24 months
postpartum.
Primary analysis: proportion re-starting smoking
Figure 2 demonstrates the primary meta-analysis using
data from the 11 studies which provided continuous absti-
nence data. The pooled mean estimate of the proportion of
women re-starting smoking by 6 months postpartum is
43% (95%CI = 16–72%, I2=96.7%). Only six studies were
included in the subgroup analysis [39,43–45,47,48],
with biochemically validated continuous abstinence data
Figure 2 Forest plot of the proportion of women re-starting smoking using continuous abstinence, with studies ordered by weighting (highest
weighting ﬁrst)
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available up to 6 months postpartum. A similar pattern of
re-starting smoking was observed in the subgroup analy-
sis; again, most women who re-started smoking had done
so within the ﬁrst 6 months after childbirth. The only dif-
ference between the primary and subgroup analyses was
that estimates for the proportions re-starting smoking
were generally higher in studies using validated data; from
studies using biochemically validated data; for example,
the pooled mean proportion of women re-starting smoking
at 6 months postpartum was 74% (95% CI = 64–82%) in
the subgroup analysis (see Supporting information, ﬁle 5).
Secondary analysis: proportion smoking
Figure 3 illustrates the meta-analysis of the proportion
smoking at different time-points among all trial partici-
pants using point-prevalence of smoking data from the
23 studies which provided this. At the end of pregnancy,
the pooled mean estimate of the proportion smoking was
87% (95% CI = 84–90%, I2 = 93.2%), and at 6 months
postpartum the pooled mean estimate of the proportion
smoking was 94% (95% CI = 92–96%, I2 = 88.0%). Sev-
enteen studies reported biochemically validated point prev-
alence abstinence [42–64], but again data were available
only up to 6 months postpartum. There appeared to be a
similar pattern of smoking in the subgroup analysis (i.e.
of trials providing validated outcome data) compared to
the secondary analysis (see Supporting information, ﬁle
6). Estimates of the proportion smoking were higher in
the subgroup analyses at the end of pregnancy, 3 months
and 6 months postpartum. At the end of pregnancy, the
pooled mean proportion of trial participants reporting
smoking was 89% (95% CI = 86–91%, I2 = 91.2%), while
the pooled mean proportion was 96% (95% CI = 92–99%,
I
2 = 70.7%) at 6 months postpartum.
DISCUSSION
We believe this is the ﬁrst study to investigate systemati-
cally the rates of re-starting smoking after childbirth and
we found that in smoking cessation trials, among the
minority of women abstinent at the end of pregnancy, a
mean estimate of 43% had re-started smoking by 6months
postpartum. Furthermore, there appeared to be little re-
starting of smoking after this point. A secondary analysis
estimated that, across trials, the mean proportion smoking
at the end of pregnancy was 87%, rising to 94% 6 months
later, which suggests that the majority of smoking cessa-
tion trials’ participants continue to smoke both throughout
pregnancy and after childbirth.
A strength of this work is its novelty and systematic ap-
proach which has provided, for the ﬁrst time, quantiﬁca-
tion of rates of re-starting smoking after pregnancy.
Additionally, as trial data are likely to be collected at a
consistently higher standard than cohort study or rou-
tinely collected data and aremore likely to be biochemically
veriﬁed, the review probably uses the highest quality
data available. It includes sufﬁcient trials (11) and par-
ticipants (571) to estimate the proportion of women
who re-start smoking after childbirth, and also much
more data (23 trials, and 9262 participants) which
could be used to locate this ﬁnding in the context of
smoking rates recorded in other trials that did not report
continuous abstinence.
Aweakness is the high level of heterogeneity present in
meta-analyses. We attempted to minimize heterogeneity
by aggregating data collected only at similar time-points
after pregnancy and by including only those smoking
cessation trials which women consented to join, and so
which included only women motivated to stop smoking.
Despite these measures, the I2 statistic for analyses was
high and heterogeneity is likely to have arisen from variety
in interventions delivered and in study populations. Al-
though the presence of heterogeneity means that pooled
proportions obtained frommeta-analyses should be viewed
with caution, study ﬁndings represent the ﬁrst effort to
synthesize data on postpartum smoking using the best
available data.
Relatively few studies reported longitudinal continuous
abstinence data, and this restricted the volume of data
available to estimate re-start rates. The more frequently
used outcome was 7 days’ abstinence from smoking, but
this outcome could not be used in the primary analysis
because individuals reporting abstinence in the postpar-
tum would not necessarily be the same women as those
reporting abstinence at the end of pregnancy. Instead, we
reported a cross-sectional analysis of smoking rates esti-
mated from point prevalence smoking rates to give context
to re-start rates estimated using longitudinal data. How-
ever, in an analysis of non-pregnant smokers and quitters,
prolonged and point prevalencemeasures of smoking absti-
nence after quitting recorded at the same time-points were
correlated closely; the ratio of prolonged to point preva-
lence abstinence was 0.74 (95% CI = 0.70–0.79) [66]
Our review suggests similarly that using either
self-reported prolonged or point prevalence abstinence
measures to estimate rates of re-starting smoking can give
similar ﬁndings. Using longitudinal data, we found that a
mean 43% of women had re-started smoking by 6 months
postpartum. Using the estimated mean proportions of
smoking at the end of pregnancy (87%) and 6 months
postpartum (94%), it can be assumed that 13% of women
are abstinent at delivery but only 6% remain so at
6 months, hence the proportion re-starting is estimated
crudely from cross-sectional point prevalence data as
(7/13 × 100) or 54%. The similarity in re-start rates
obtained using either longitudinal or cross-sectional data
suggests that change in smoking status in the postpartum
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is generally in one direction, from not smoking to smoking.
If many women re-started and stopped smoking repeatedly
after childbirth, one would expect different ﬁndings to arise
from estimates of re-starting smoking made using these
different outcome measures.
As this review includes only trials in which pregnant
smokers showed motivation to stop smoking by consenting
to join a smoking cessation study, ﬁndings are likely to be
generalizable to those pregnant smokers who seek support
from health-care providers with cessation attempts.
Figure 3 Forest plot of the proportion of women smoking among all trial participants based on 7-day point prevalence abstinence, with studies
ordered by weighting (highest weighting ﬁrst)
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Unfortunately, most of these women do not manage to stop
smoking in pregnancy, and nearly half of those who do
re-start smoking within 6 months of childbirth. Addi-
tionally, although there is no similar review which inves-
tigates rates of re-starting smoking among women who
stop smoking in pregnancy without receiving support
(‘spontaneous quitters’), comparison with individual
studies suggests that rates may be broadly similar. We
estimated that mean proportions of women re-starting
at 6, 12 and 24 months postpartum were 43, 47 and
62%, respectively, whereas individual observational
studies of ‘spontaneous quitters’ provide estimates of
proportions re-starting of 30–76% [67–77], 32–59%
[29,30,71,72] and 59% [27] at these time-points.
CONCLUSIONS
Most pregnant smokers do not achieve abstinence from
smoking while they are pregnant, and among those that
do, most will re-start smoking within 6 months of child-
birth. This would suggest that despite large amounts of
health-care expenditure on smoking cessation, fewwomen
and their offspring gain themaximum beneﬁts of cessation.
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